After the intelligence gene, the faith gene… here’s the empathy gene !
A recent publication has been hailed by the media as the proof that empathy has a genetic origin. It is unfortunate that journalists do not bother to read scientific articles […]
AN ANSWER TO ERWAN BÉZARD
Following the recent publication of a paper called “GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease“, Erwan Bézard, director of the Neurodégénérative Diseases Institute of […]
An answer to Prof Tepper about his short comment on our recently published paper
We recently published a paper called “GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease“. Prof Tepper briefly commented it on Twitter. Here’s our answer: […]
Bumetanide strikes again in the arena of neurological disorders: a novel therapeutic approach to treat Parkinson’s disease
A new study led by Prs. Yehezkel Ben-Ari & Constance Hammond (Neurochlore and B&A Therapeutics, Marseille, France) demonstrates that bumetanide, an antagonist of the NKCC1 chloride importer, normalizes the activity […]
Bumetanide for autism: more eye contact, less amygdala activation
Bumetanide for autism: more eye contact, less amygdala activation Nouchine Hadjikhani (Martinos Center for Biomedical Imaging, Harvard Medical School, Boston, Etats-Unis et Université de Gothenburg, Gothenburg, Suède), Eric Lemonnier (Centre […]
Childbirth and the multiple facets of a hormone : oxytocin
The birth process took millions of years to be developed. It must allow 4 major reactions: a passage from an immunologically protected environment to the external environment, the acquisition of […]
Plea for biomedical innovation
A large part of the therapeutic applications of biomedical research is generated in innovation incubators. More than 70% of new drugs come from discoveries made by small structures close to […]
